A Statement of the Committee of the Society for Metabolic Bone Diseases within the Czech Medical Association of J.E. Purkyně on the repeated inaccurate data concerning the risk of osteonecrosis of the jaw in antiresorptive treatment of osteoporosis
Authors:
Palička Vladimír; Rosa Jan
Authors‘ workplace:
Výbor Společnosti pro metabolická onemocnění skeletu ČLS JEP
Published in:
Clinical Osteology 2019; 24(3): 107-108
Category:
Labels
Clinical biochemistry Paediatric gynaecology Paediatric radiology Paediatric rheumatology Endocrinology Gynaecology and obstetrics Internal medicine Orthopaedics General practitioner for adults Radiodiagnostics Rehabilitation Rheumatology Traumatology OsteologyArticle was published in
Clinical Osteology
2019 Issue 3
- Memantine Eases Daily Life for Patients and Caregivers
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Metamizole vs. Tramadol in Postoperative Analgesia
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
Most read in this issue
- XXII. mezinárodní kongres českých a slovenských osteologů
- Osteoporosis in men: what changed?
- ODPORÚČANIE SOMOK
- An overview of non-pharmacological prevention of fracture in the area of osteopathies with a focus on physical strain